Skip to the page

Data / Form D filings / Transcarent, Inc.

Transcarent, Inc.: Form D filing

Transcarent, Inc., a health care company in Denver, CO, filed a Form D with the SEC in 2025. The latest, on April 22, 2025, reports $481 million sold of a $700 million offering to 33 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4700 S. SYRACUSE STREET, SUITE 900, Denver, CO, 80237
Phone
(610) 834-2989
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2065307

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 22, 2025New notice$699,999,999$480,999,962$219,000,03733Apr 7, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephanie PengExecutive Officer
Lee ShapiroExecutive Officer, Director
Ken FrazierDirector
Holly MaloneyDirector
Hemant TanejaDirector
Erica DavilaExecutive Officer
Glen TullmanExecutive Officer, Director

Other health care companies in Colorado that filed recently

Every Form D from the week of Apr 21, 2025 · All recent filings in Colorado · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Transcarent, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.